drugset
drugset / Trial / NCT05152381

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Osteoporosis

NCT05152381 ↗

Phase 1 Withdrawn The Foundation for Orthopaedics and Regenerative Medicine
NaSingle-groupOpen-labelTreatment

Summary

This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Osteoporosis

Timeline

Start
2022-12-08
Primary completion
2025-04-04
Completion
2025-04-04

Drugs

EvaluationDrugModalityDoseRoute
Subject AlloRx Cell therapy 1e+08 cells Intravenous

Indications

osteoporosis